|
SECISBP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.34569999588052E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.55420001710394E-09 |
| Normal-vs-Stage2 |
7.787200E-04 |
| Normal-vs-Stage3 |
2.32210028983104E-10 |
| Normal-vs-Stage4 |
3.47140000078738E-08 |
| Stage1-vs-Stage2 |
9.182000E-01 |
| Stage1-vs-Stage3 |
1.893740E-02 |
| Stage1-vs-Stage4 |
2.792000E-02 |
| Stage2-vs-Stage3 |
8.407600E-02 |
| Stage2-vs-Stage4 |
1.348160E-01 |
| Stage3-vs-Stage4 |
8.177600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.27339996511967E-09 |
| Normal-vs-AfricanAmerican |
2.92190005524162E-09 |
| Normal-vs-Asian |
4.16410000037004E-07 |
| Caucasian-vs-AfricanAmerican |
2.628600E-01 |
| Caucasian-vs-Asian |
1.050760E-01 |
| AfricanAmerican-vs-Asian |
1.091800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.31879976225957E-10 |
| Normal-vs-Female |
2.04149999999403E-05 |
| Male-vs-Female |
2.401000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.31789999983035E-07 |
| Normal-vs-Extreme_Weight |
1.58059999977311E-07 |
| Normal-vs-Obese |
6.84199999989588E-07 |
| Normal-vs-Extreme_Obese |
3.80290000000505E-05 |
| Normal_Weight-vs-Extreme_Weight |
7.966400E-01 |
| Normal_Weight-vs-Obese |
5.201200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.539400E-01 |
| Extreme_Weight-vs-Obese |
6.989600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.736000E-01 |
| Obese-vs-Extreme_Obese |
4.734800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.12609999999946E-05 |
| Normal-vs-Age(41-60Yrs) |
2.18080000002896E-06 |
| Normal-vs-Age(61-80Yrs) |
1.44010026126296E-10 |
| Normal-vs-Age(81-100Yrs) |
1.404870E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.311600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.314800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.067800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.039900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.444160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.522800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.00680000009379E-07 |
| Normal-VS-Type2 PRCC |
7.31636973227978E-13 |
| Normal-VS-KIRP CIMP |
4.03920000002778E-07 |
| Normal-VS-Unclassified PRCC |
1.014210E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.29020000000113E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.329800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.213200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.486400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.522840E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.322000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.13570280852105E-11 |
| Normal-vs-N1 |
8.65450000553381E-09 |
| Normal-vs-N2 |
4.41860000000016E-06 |
| N0-vs-N1 |
7.889800E-01 |
| N0-vs-N2 |
2.134800E-01 |
| N1-vs-N2 |
3.067800E-01 |
|
|
